Additional studies in progress advise that ARV-825 may also be effective in improving the reaction to estrogen deprivation (aromatase inhibition), another ingredient of standard of care in ER+ breast cancer. - "Our study unveiled the very important position from the KLF16/MYC regulatory axis in modulating tumor expansion and chemotherapy sensitivity https://abbv-744forsmallcelllungc13467.therainblog.com/31104321/5-tips-about-clinical-effectiveness-of-abbv-744-in-aml-patients-you-can-use-today